Shares of the Chicago-based company rose more than 2% in
premarket trading.
Due to the impairment charges, the company reported a
second-quarter loss attributable to common shareholders of $1.65
billion, or $1.35 per share, compared with a profit of $449
million, or 37 cents a share a year earlier.
Excluding items, adjusted earnings were 80 cents per share,
handily beating analysts' average estimate of 65 cents,
according to Refinitiv.
Sales rose 3.8% to $6.65 billion in the second quarter ended
June 27, beating expectations for $6.54 billion.
(Reporting by Richa Naidu; editing by Jason Neely and Bernadette
Baum)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|